Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05829109 · ClinicalTrials.gov registry record · Early Phase 1
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
A Early Phase 1 study of Pouchitis and Chronic Pouchitis, sponsored by Maia Kayal.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05829109 is a Early Phase 1 study of Pouchitis and Chronic Pouchitis that is actively recruiting participants, run by Maia Kayal. The registered enrollment target is 16 participants, below the 24-participant average among 5 other Pouchitis trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05829109, a Early Phase 1 study of Pouchitis and Chronic Pouchitis, is actively recruiting participants, sponsored by Maia Kayal.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis.
Conditions Studied
Interventions
- DRUG Fecal Microbiota Transplant (FMT)
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05829109
The ClinicalTrials.gov registry entry for NCT05829109 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 24-participant average among 5 other Pouchitis trials with a reported enrollment target (33% lower). The listed sponsor is Maia Kayal, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pouchitis appearing as the primary indexed condition, and to 1 intervention - of which Fecal Microbiota Transplant (FMT) is the first listed.
NCT05829109 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05829109 about?
NCT05829109 is a clinical study titled "Fecal Microbiota Transplant for Patients With Chronic Pouchitis". The purpose of this research study is to assess the safety and efficacy of fecal microbiota transplant (FMT) in the treatment of chronic pouchitis.
What is the current status of trial NCT05829109?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2024-09-01. Estimated completion is 2026-12.
What conditions does trial NCT05829109 study?
This clinical trial studies the following conditions: Pouchitis, Chronic Pouchitis.
What interventions are being tested in trial NCT05829109?
The interventions under investigation include: Fecal Microbiota Transplant (FMT) (DRUG).
Who is sponsoring clinical trial NCT05829109?
This trial is sponsored by Maia Kayal, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05829109 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pouchitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
RECRUITING · Phase 4
-
CLF065 for Chronic Pouchitis
RECRUITING · Phase 2
-
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
RECRUITING · Phase 4
-
Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis
COMPLETED · NA
-
Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With IPAA
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.